临床表现 临床表现
Emilie V Brotherhood1,2, Coty Chen1, Claire J Cadwallader1
1Memory and Aging Center, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
FitbitTM活动数据揭示了前叶退行症 (FTLD) 患者的明显模式. 这些休息活动模式与轻度认知障碍或健康个体的休息活动模式有很大不同.
科学领域:
- 神经科学是一个神经科学.
- 老年学是指老年学的学科.
- 生物医学工程 生物医学工程
背景情况:
- 阿尔茨海默病和相关痴呆症 (ADRD) 显著影响睡眠-清醒周期.
- 商业可穿戴设备为现实世界监控提供可扩展的被动动动图.
- 描述休息活动模式可以揭示健康成年人和ADRD队列之间的差异.
研究的目的:
- 使用FitbitTM数据来描述连续休息活动模式.
- 为了检查健康成年人和各种ADRD队列之间的这些模式的差异.
- 调查活动模式与认知/功能衰退之间的关联.
主要方法:
- 收集了健康成年人,轻度认知障碍 (MCI),阿尔茨海默氏病 (AD) 和前叶退化 (FTLD) 队列的三轴动图,临床,认知,功能和情绪数据.
- 使用休息活动总和分钟级步数特征的量化活动模式.
- 应用主要组件分析 (PCA) 来减少数据,并确定了解释>85%的差异的五个组件.
主要成果:
- 主要组件1 (PC1),代表活动变化和振幅,与认知和功能下降得分 (CDR®+FTLD-NACC) 有负相关性.
- PC1也显示出显著的诊断组差异,与健康和MCI组相比,FTLD患者的PC1得分下降.
- 与休息活动开始时间相关的PC3与全球认知得分有负相关性.
结论:
- 来自FitbitTM数据的活动变异性和幅度突出显示了FTLD综合征中的独特行为特征.
- 这些不同的活动概况使FTLD患者与患有MCI或功能完整的患者有区别.
- 通过可穿戴设备的被动动动图提供了对神经退行性疾病进展的宝贵见解.
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
520
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
Coronary Artery Disease III: Clinical Manifestations
299
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
299
Endocarditis II: Clinical Features of Infective Endocarditis
364
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
364
Heart Failure III: Clinical Manifestations
436
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
436
Gastroesophageal Reflux Disease II: Clinical Features and Management
652
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
652
Hypertension III: Clinical Manifestations and Diagnostic Studies
437
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437


